These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36688162)

  • 21. Effect of traumatic brain injury on mild behavioral impairment domains prior to all-cause dementia diagnosis and throughout disease progression.
    Bray MJC; Bryant BR; Esagoff AI; Richey LN; Rodriguez C; Krieg A; McCullough G; Tsai J; Tobolowsky W; Jahed S; Cullum CM; LoBue C; Ismail Z; Yan H; Lyketsos CG; Peters ME
    Alzheimers Dement (N Y); 2022; 8(1):e12364. PubMed ID: 36514440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
    Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of mild behavioral impairment in patients with mild cognitive impairment.
    Kianimehr G; Fatehi F; Noroozian M
    Acta Neurol Belg; 2022 Dec; 122(6):1493-1497. PubMed ID: 34191260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.
    Ismail Z; Agüera-Ortiz L; Brodaty H; Cieslak A; Cummings J; Fischer CE; Gauthier S; Geda YE; Herrmann N; Kanji J; Lanctôt KL; Miller DS; Mortby ME; Onyike CU; Rosenberg PB; Smith EE; Smith GS; Sultzer DL; Lyketsos C;
    J Alzheimers Dis; 2017; 56(3):929-938. PubMed ID: 28059789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma β-Amyloid in Mild Behavioural Impairment - Neuropsychiatric Symptoms on the Alzheimer's Continuum.
    Miao R; Chen HY; Gill S; Naude J; Smith EE; Ismail Z;
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):434-441. PubMed ID: 34036829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    Tsunoda K; Yamashita T; Osakada Y; Sasaki R; Tadokoro K; Matsumoto N; Nomura E; Morihara R; Nakano Y; Takahashi Y; Hatanaka N; Shang J; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Alzheimers Dis; 2020; 73(1):209-215. PubMed ID: 31771056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults.
    Mortby ME; Ismail Z; Anstey KJ
    Int Psychogeriatr; 2018 Feb; 30(2):221-232. PubMed ID: 28931446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C).
    Stella F; Pais MV; Loureiro JC; Radanovic M; Forlenza OV
    Psychogeriatrics; 2022 Jan; 22(1):55-66. PubMed ID: 34704636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases.
    Ferraro PM; Gervino E; De Maria E; Meo G; Ponzano M; Pardini M; Signori A; Schenone A; Roccatagliata L; Caponnetto C
    Eur J Neurol; 2023 Jan; 30(1):47-56. PubMed ID: 36148819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    El Haffaf LM; Ronat L; Cannizzaro A; Hanganu A;
    J Alzheimers Dis; 2024; 97(2):841-853. PubMed ID: 38143342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic.
    Matsuoka T; Ismail Z; Narumoto J
    J Alzheimers Dis; 2019; 70(2):505-513. PubMed ID: 31177229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.
    Ruthirakuhan M; Ismail Z; Herrmann N; Gallagher D; Lanctôt KL
    Alzheimers Dement; 2022 Nov; 18(11):2199-2208. PubMed ID: 35103400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults.
    Gonzalez-Bautista E; Momméja M; de Mauléon A; Ismail Z; Vellas B; Delrieu J; Soto Martin ME
    Alzheimers Dement; 2024 Jul; 20(7):4692-4701. PubMed ID: 38877658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Xu L; Li T; Xiong L; Wang X; Ismail Z; Fukuda M; Sun Z; Wang J; Gauthier S; Yu X; Wang H
    J Alzheimers Dis; 2021; 81(3):1141-1149. PubMed ID: 33935092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.
    Taragano FE; Allegri RF; Heisecke SL; Martelli MI; Feldman ML; Sánchez V; García VA; Tufro G; Castro DM; Leguizamón PP; Guelar V; Ruotolo E; Zegarra C; Dillon C
    J Alzheimers Dis; 2018; 62(1):227-238. PubMed ID: 29439333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.
    Mallo SC; Ismail Z; Pereiro AX; Facal D; Lojo-Seoane C; Campos-Magdaleno M; Juncos-Rabadán O
    J Alzheimers Dis; 2018; 66(1):83-95. PubMed ID: 30175974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTAD Task Force Paper: Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force.
    Soto M; Rosenberg P; Ballard C; Vellas B; Miller D; Gauthier S; Carrillo MC; Lyketsos C; Ismail Z
    J Prev Alzheimers Dis; 2024; 11(1):56-64. PubMed ID: 38230717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.
    Li K; Qu H; Ma M; Xia C; Cai M; Han F; Zhang Q; Gu X; Ma Q
    Front Aging Neurosci; 2022; 14():816043. PubMed ID: 35547625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.